Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

Name: Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)
License: Public Domain

Association NVALT Studies

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non small

carcinoma, non-small-cell lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 432881
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.